PT Kalbe Farma Tbk (ISX:KLBF) Other Current Receivables: Rp286,581 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ISX:KLBF PT Kalbe Farma Tbk ISX:KLBF
81 GF Score
Price Rp750.00
GF Value Rp1,741.67
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is PT Kalbe Farma Tbk Other Current Receivables?

PT Kalbe Farma Tbk ISX:KLBF -1.94% 81 Other Current Receivables is Rp286,581 Mil as of Jun. 2026. GuruFocus rates ISX:KLBF with a GF Score™ of 81/100 and a GF Value™ of Rp1,741.67 (Significantly Undervalued). The stock has 3 warning signs investors should review.

PT Kalbe Farma Tbk's Other Current Receivables for the quarter that ended in Jun. 2026 was Rp286,581 Mil.

PT Kalbe Farma Tbk's quarterly Other Current Receivables increased from Dec. 2025 (Rp245,037.00 Mil) to Mar. 2026 (Rp279,211.00 Mil) and increased from Mar. 2026 (Rp279,211.00 Mil) to Jun. 2026 (Rp286,581.00 Mil).

PT Kalbe Farma Tbk's annual Other Current Receivables declined from Dec. 2023 (Rp168,170.21 Mil) to Dec. 2024 (Rp148,612.65 Mil) but then increased from Dec. 2024 (Rp148,612.65 Mil) to Dec. 2025 (Rp245,037.00 Mil).

PT Kalbe Farma Tbk Other Current Receivables Related Terms

PT Kalbe Farma Tbk Other Current Receivables Historical Data

* Premium members only.

The historical data trend for PT Kalbe Farma Tbk's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Kalbe Farma Tbk Other Current Receivables Chart

PT Kalbe Farma Tbk Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 114,124.56 174,144.81 168,170.21 148,612.65 245,037.00

PT Kalbe Farma Tbk Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 198,847.08 216,328.08 245,037.00 279,211.00 286,581.00
ISX:KLBF
81GF Score
PT Kalbe Farma Tbk ISX:KLBF
Other Current Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PT Kalbe Farma Tbk Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of Rp286,581 Mil mean?
PT Kalbe Farma Tbk (ISX:KLBF) has a Other Current Receivables of Rp286,581 Mil as of Jun. 2026. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on PT Kalbe Farma Tbk and its competitors.
Is PT Kalbe Farma Tbk's Other Current Receivables too high?
PT Kalbe Farma Tbk's current Other Current Receivables is Rp286,581 Mil. Overall, PT Kalbe Farma Tbk has a GF Score™ of 81/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Kalbe Farma Tbk's Other Current Receivables compare to LLY and JNJ?
PT Kalbe Farma Tbk's Other Current Receivables of Rp286,581 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Drug Manufacturers company?
A good Other Current Receivables depends on the Drug Manufacturers industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on PT Kalbe Farma Tbk and its competitors. PT Kalbe Farma Tbk's current Other Current Receivables is Rp286,581 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Kalbe Farma Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Kalbe Farma Tbk (ISX:KLBF) is currently considered Significantly Undervalued. The stock's GF Value™ is Rp1,741.67, compared to a current price of Rp750.00 — trading 56.9% below its estimated fair value. The current Other Current Receivables is Rp286,581 Mil. PT Kalbe Farma Tbk's overall GF Score™ is 81/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For PT Kalbe Farma Tbk (ISX:KLBF), the current Other Current Receivables is Rp286,581 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PT Kalbe Farma Tbk (ISX:KLBF) Overvalued in 2026?

Based on GuruFocus' analysis, PT Kalbe Farma Tbk stock appears to be undervalued. The current stock price of Rp750.00 is trading 56.9% below its estimated GF Value™ of Rp1,741.67. GuruFocus considers PT Kalbe Farma Tbk to be Significantly Undervalued.

Key valuation signals for ISX:KLBF:

  • Other Current Receivables: Rp286,581 Mil
  • GF Value™: Rp1,741.67 vs. price of Rp750.00 (56.9% below fair value)
  • GF Score™: 81/100 with 3 warning signs

No single metric tells the full story. See the ISX:KLBF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

PT Kalbe Farma Tbk Business Description

Address Jalan Let. Jend. Suprapto Kav. 4, Gedung KALBE, Cempaka Putih, P.O. Box 3105, Jakarta, IDN, 10510
PT Kalbe Farma Tbk is an Indonesian pharmaceutical company engaged in the development, manufacturing, and distribution of healthcare products. It operates through divisions covering prescription pharmaceuticals, consumer health, nutritionals, and distribution and logistics, with a portfolio spanning prescription medicines, over-the-counter drugs, vitamins, supplements, and medical devices. Its brands include Promag, Mixagrip, Extra Joss, and Hydro Coco, among others. The company serves patients, consumers, pharmacies, hospitals, and healthcare professionals, primarily in Indonesia, with additional exports to Southeast Asian and other international markets. Revenue is generated through the sale of pharmaceutical and consumer health products, nutritional goods, and distribution services, supported by an extensive domestic distribution network. Kalbe Farma is one of the largest publicly listed pharmaceutical companies in Southeast Asia.
81GF Score

Get the complete analysis for ISX:KLBF

Other Current Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp750.00
Price
Rp1,741.67
GF Value